Table 6.
Compound | IC50a (μM) | Ratiob | |
---|---|---|---|
Early Stage | Late Stage | ||
6k | 8.22 ± 0.99 | 4.20 ± 2.51 | 0.51 |
8a | 1.94 ± 0.48 | 2.44 ± 1.52 | 1.26 |
11l | 8.96 ± 0.43nM | 0.24 ± 0.11 | 26.79 |
PF-74 | 56 ± 17 nM | 0.23 ± 0.17 | 4.11 |
the concentration of the compound required to achieve 50% infection of HIV-1 Env-pseudotyped virus in U87.CD4.CCR5 target cells. SD of 3 parallel tests is indicated.
IC50Late/IC50Early ratio.